Atlas Trials

Pembrolizumab Cyclophosphamide and Lenalidomide for Patients With Relapsed Multiple Myeloma

Clinical trial NCT03191981 · WITHDRAWN

Trial details

NCT number
NCT03191981
Sponsor
University of Leeds
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Myeloma Multiple
Start date
2017-08-01
Primary completion
2017-08-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.